These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 15983437)

  • 1. What can we learn from animal models of Alopecia areata?
    McElwee KJ; Yu M; Park SW; Ross EK; Finner A; Shapiro J
    Dermatology; 2005; 211(1):47-53. PubMed ID: 15983437
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alopecia areata: pathogenesis and potential for therapy.
    Lu W; Shapiro J; Yu M; Barekatain A; Lo B; Finner A; McElwee K
    Expert Rev Mol Med; 2006 Jun; 8(14):1-19. PubMed ID: 16787552
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alopecia areata in C3H/HeJ mice involves leukocyte-mediated root sheath disruption in advance of overt hair loss.
    McElwee KJ; Silva K; Boggess D; Bechtold L; King LE; Sundberg JP
    Vet Pathol; 2003 Nov; 40(6):643-50. PubMed ID: 14608017
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The pathogenesis of alopecia areata in rodent models.
    McElwee KJ; Freyschmidt-Paul P; Sundberg JP; Hoffmann R
    J Investig Dermatol Symp Proc; 2003 Jun; 8(1):6-11. PubMed ID: 12894987
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is alopecia areata an autoimmune-response against melanogenesis-related proteins, exposed by abnormal MHC class I expression in the anagen hair bulb?
    Paus R; Slominski A; Czarnetzki BM
    Yale J Biol Med; 1993; 66(6):541-54. PubMed ID: 7716973
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic susceptibility and severity of alopecia areata in human and animal models.
    McElwee K; Freyschmidt-Paul P; Ziegler A; Happle R; Hoffmann R
    Eur J Dermatol; 2001; 11(1):11-6. PubMed ID: 11174130
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interferon-gamma-deficient mice are resistant to the development of alopecia areata.
    Freyschmidt-Paul P; McElwee KJ; Hoffmann R; Sundberg JP; Vitacolonna M; Kissling S; Zöller M
    Br J Dermatol; 2006 Sep; 155(3):515-21. PubMed ID: 16911275
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of vascular endothelial growth factor, apoptosis inhibitors (survivin and p16) and CCL27 in alopecia areata before and after diphencyprone treatment: an immunohistochemical study.
    Simonetti O; Lucarini G; Bernardini ML; Simoncini C; Biagini G; Offidani A
    Br J Dermatol; 2004 May; 150(5):940-8. PubMed ID: 15149507
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alopecia areata: a tissue specific autoimmune disease of the hair follicle.
    Gilhar A; Kalish RS
    Autoimmun Rev; 2006 Jan; 5(1):64-9. PubMed ID: 16338213
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alopecia areata: autoimmune basis of hair loss.
    Alexis AF; Dudda-Subramanya R; Sinha AA
    Eur J Dermatol; 2004; 14(6):364-70. PubMed ID: 15564197
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo depletion of CD8+ T cells restores hair growth in the DEBR model for alopecia areata.
    McElwee KJ; Spiers EM; Oliver RF
    Br J Dermatol; 1996 Aug; 135(2):211-7. PubMed ID: 8881662
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of alopecia areata in human and nonhuman mammalian species.
    McElwee KJ; Boggess D; Olivry T; Oliver RF; Whiting D; Tobin DJ; Bystryn JC; King LE; Sundberg JP
    Pathobiology; 1998; 66(2):90-107. PubMed ID: 9645633
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alopecia areata: Animal models illuminate autoimmune pathogenesis and novel immunotherapeutic strategies.
    Gilhar A; Schrum AG; Etzioni A; Waldmann H; Paus R
    Autoimmun Rev; 2016 Jul; 15(7):726-35. PubMed ID: 26971464
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Treatment of alopecia areata: modern principles and perspectives].
    Brajac I; Kastelan M; Perisa D; Simonić E; Stojnić-Sosa L; Massari LP
    Lijec Vjesn; 2010; 132(11-12):365-9. PubMed ID: 21294327
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alopecia areata.
    King LE; McElwee KJ; Sundberg JP
    Curr Dir Autoimmun; 2008; 10():280-312. PubMed ID: 18460892
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epidemiologic and genetic characteristics of alopecia areata (part 1).
    Alzolibani AA
    Acta Dermatovenerol Alp Pannonica Adriat; 2011; 20(4):191-8. PubMed ID: 22367375
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of cellular immunity against hair follicle melanocyte causes alopecia.
    Nagai H; Oniki S; Oka M; Horikawa T; Nishigori C
    Arch Dermatol Res; 2006 Aug; 298(3):131-4. PubMed ID: 16786344
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Partial restoration of hair growth in the DEBR model for Alopecia areata after in vivo depletion of CD4+ T cells.
    McElwee KJ; Spiers EM; Oliver RF
    Br J Dermatol; 1999 Mar; 140(3):432-7. PubMed ID: 10233262
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alopecia areata update: part I. Clinical picture, histopathology, and pathogenesis.
    Alkhalifah A; Alsantali A; Wang E; McElwee KJ; Shapiro J
    J Am Acad Dermatol; 2010 Feb; 62(2):177-88, quiz 189-90. PubMed ID: 20115945
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Normalisation of hair follicle morphology in C3H/HeJ alopecia areata mice after treatment with squaric acid dibutylester.
    Gardner S; Freyschmidt-Paul P; Hoffmann R; Sundberg JP; Happle R; Lindsey NJ; Tobin DJ
    Eur J Dermatol; 2000 Aug; 10(6):443-50. PubMed ID: 10980465
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.